Keywords: heptares, raises, gbp21m, finance, pipeline, london, uk-based
Heptares raises GBP21M to finance pipeline
Article | 02 March 2009
London, UK-based Heptares Therapeutics, a drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), has raised GBP21.0 million ($30.6 million) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
